Severe bacteremia results in a loss of hepatic bacterial clearance

被引:35
作者
Ashare, A [1 ]
Monick, MM [1 ]
Powers, LS [1 ]
Yarovinsky, T [1 ]
Hunninghake, GW [1 ]
机构
[1] Vet Adm Med Ctr, Iowa City, IA USA
关键词
apoptosis; bacteremia; infection;
D O I
10.1164/rccm.200509-1470OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Although it has been postulated that liver injury results in impaired clearance of bacteria from the blood, no prior study has evaluated hepatic bacterial clearance during sepsis. Objectives: We hypothesized that liver injury during the evolution of sepsis would result in impaired hepatic bacterial clearance. Methods: Mild and severe bacteremia were generated in C57BL/6 mice by low- and high-dose intratracheal inoculation with Pseudomonas aeruginosa. Measurements and Main Results: The mortality rates with mild and severe bacteremia were 20% and 60%, respectively. Hepatic bacterial clearance was preserved throughout the evolution of mild bacteremia but was lost late with severe bacteremia. The loss of hepatic bacterial clearance resulted in increased systemic bacteremia and mortality. Pretreatment with a caspase inhibitor resulted in preservation of hepatic bacterial clearance with severe bacteremia and eventual control of the bacteremia. When Kupffer cells were ablated before the onset of bacteremia, there was a loss of hepatic bacterial clearance. This converted an initially mild bacteremia into severe bacteremia with increased organ injury and mortality. Conclusions: These observations suggest that hepatic bacterial clearance may be lost during the evolution of sepsis, resulting in a failure to control bacteremia. Thus, the capacity of the liver to clear bacteria is an important determinant of the outcome in sepsis.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 46 条
[1]   Systemic inflammatory response and progression to severe sepsis in critically ill infected patients [J].
Alberti, C ;
Brun-Buisson, C ;
Chevret, S ;
Antonelli, M ;
Goodman, SV ;
Martin, C ;
Moreno, R ;
Ochagavia, AR ;
Palazzo, M ;
Werdan, K ;
Le Gall, JR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (05) :461-468
[2]  
Arii S, 2000, J Hepatobiliary Pancreat Surg, V7, P40, DOI 10.1007/s005340050152
[3]   BLOOD CULTURES [J].
ARONSON, MD ;
BOR, DH .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :246-253
[4]   Severe sepsis is associated with an apoptosis-mediated decrease in hepatic bacterial clearance [J].
Ashare, A ;
Yarovinsky, T ;
Monick, M ;
Hunninghake, G .
CHEST, 2005, 128 (04) :379S-379S
[5]   Anti-inflammatory response is associated with mortality and severity of infection in sepsis [J].
Ashare, A ;
Powers, LS ;
Butler, NS ;
Doerschug, KC ;
Monick, MM ;
Hunninghake, GW .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 288 (04) :L633-L640
[6]  
ASHARE A, 2005, P AM THORAC SOC, V2, pA40
[7]   Novel murine model of pneumococcal pneumonia: Use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin [J].
Bast, DJ ;
Yue, M ;
Chen, X ;
Bell, D ;
Dresser, L ;
Saskin, R ;
Mandell, LA ;
Low, DE ;
de Azavedo, JCS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3343-3348
[8]   Akt decreases lymphocyte apoptosis and improves survival in sepsis [J].
Bommhardt, U ;
Chang, KC ;
Swanson, PE ;
Wagner, TH ;
Tinsley, KW ;
Karl, IE ;
Hotchkiss, RS .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7583-7591
[9]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[10]  
CALLERY MP, 1990, ARCH SURG-CHICAGO, V125, P36